Developing a predictive model for neoadjuvant therapy in HER2 overexpression breast cancer using multi-parameter MRI radiomics: two-center retrospective study

The nomogram model based on multi-parameter MRI has a steady performance in predicting the efficacy of NAT in breast cancer patients with HER2 overexpression, which provides important guidance for clinical treatment and decision-making.